Loading...
DENTSPLY SIRONA Inc.
XRAY•NASDAQ
Healthcare
Medical - Instruments & Supplies
$16.03
$-0.43(-2.61%)
DENTSPLY SIRONA Inc. (XRAY) Financial Performance & Income Statement Overview
Review DENTSPLY SIRONA Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.34%
↓ 4.34%
Operating Income Growth
-934.12%
↓ 934.12%
Net Income Growth
-589.39%
↓ 589.39%
Operating Cash Flow Growth
22.28%
↑ 22.28%
Operating Margin
-23.07%
↓ 23.07%
Gross Margin
51.60%
↑ 51.60%
Net Profit Margin
-24.42%
↓ 24.42%
ROE
-38.20%
↓ 38.20%
ROIC
-20.16%
↓ 20.16%
DENTSPLY SIRONA Inc. (XRAY) Income Statement & Financial Overview
Review DENTSPLY SIRONA Inc.'s (XRAY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $905.00M | $951.00M | $984.00M | $953.00M |
| Cost of Revenue | $459.00M | $456.00M | $472.00M | $447.00M |
| Gross Profit | $446.00M | $495.00M | $512.00M | $506.00M |
| Gross Profit Ratio | $0.49 | $0.52 | $0.52 | $0.53 |
| R&D Expenses | $42.00M | $40.00M | $41.00M | $42.00M |
| SG&A Expenses | $401.00M | $391.00M | $398.00M | $417.00M |
| Operating Expenses | $955.00M | $957.00M | $439.00M | $459.00M |
| Total Costs & Expenses | $1.41B | $1.41B | $911.00M | $906.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $16.00M | $18.00M | $17.00M | $18.00M |
| Depreciation & Amortization | $88.00M | $89.00M | $86.00M | $86.00M |
| EBITDA | -$425.00M | -$371.00M | $157.00M | $136.00M |
| EBITDA Ratio | -$0.47 | -$0.39 | $0.16 | $0.14 |
| Operating Income | -$509.00M | -$462.00M | $73.00M | $42.00M |
| Operating Income Ratio | -$0.56 | -$0.49 | $0.07 | $0.04 |
| Other Income/Expenses (Net) | -$14.00M | -$16.00M | -$16.00M | -$11.00M |
| Income Before Tax | -$523.00M | -$478.00M | $34.00M | $31.00M |
| Income Before Tax Ratio | -$0.58 | -$0.50 | $0.03 | $0.03 |
| Income Tax Expense | -$95.00M | $17.00M | $38.00M | $14.00M |
| Net Income | -$430.00M | -$494.00M | -$4.00M | $18.00M |
| Net Income Ratio | -$0.48 | -$0.52 | -$0.004 | $0.02 |
| EPS | -$2.16 | -$2.46 | -$0.02 | $0.09 |
| Diluted EPS | -$2.16 | -$2.46 | -$0.02 | $0.09 |
| Weighted Avg Shares Outstanding | $198.80M | $201.00M | $205.60M | $207.40M |
| Weighted Avg Shares Outstanding (Diluted) | $198.80M | $201.00M | $205.60M | $208.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan